Streetbeat News

Products Services

SANA

Sana Biotechnology has published novel in vivo preclinical data in Nature Biotechnology, showing the potential of their pluripotent stem cell-derived human glial progenitor cell transplantation as a treatment for Huntington's disease and other glial-based neurodegenerative conditions. The data demonstrated that healthy transplanted human glial cells could replace diseased glial cells in the brains of human glial chimeric Huntingtin mice, providing additional proof-of-concept for the advancement of SC379, Sana's product candidate.

Portfolio Pulse from Benzinga Newsdesk

May 21, 2024 | 1:02 pm

PPG

PPG Industries is set to invest $300 million in advanced manufacturing in North America, focusing on automotive coatings. The investment will enhance production capabilities at its Cleveland, Ohio, and San Juan Del Rio, Mexico facilities.

Portfolio Pulse from Benzinga Newsdesk

May 21, 2024 | 1:02 pm

XYLO

Xylo Technologies is set to acquire an AI technology company. The initial payment is €1.5 million, and Xylo will initially hold 51% of the company's outstanding shares. The remaining 49% will be acquired after determining the final transaction price.

Portfolio Pulse from Benzinga Newsdesk

May 21, 2024 | 1:01 pm

JOBY

Joby Aviation has signed a Memorandum of Understanding (MoU) with Mukamalah Aviation, a subsidiary of Saudi Aramco, to introduce eVTOL aircraft to Saudi Arabia. The agreement includes the potential direct sale of aircraft to Mukamalah, which operates the world's largest fleet of corporate aircraft.

Portfolio Pulse from Benzinga Newsdesk

May 21, 2024 | 12:51 pm

MIRA

MIRA Pharmaceuticals is in advanced discussions with Memorial Sloan Kettering Cancer Center to initiate a preclinical study on its novel oral ketamine analog, Ketamir-2, for treating cancer-related pain and depression. This collaboration could validate the potential of Ketamir-2 beyond its current preclinical studies for other disorders.

Portfolio Pulse from Benzinga Newsdesk

May 21, 2024 | 12:49 pm

SILO

Silo Pharma has reported results from a study on a new drug formulation for depression treatment, which shows potential in extending remission periods and preventing relapse in patients.

Portfolio Pulse from Benzinga Newsdesk

May 21, 2024 | 12:48 pm

PTCT

The European Commission has requested the Committee for Medicinal Products for Human Use (CHMP) to review its January opinion on the renewal of the marketing authorization for Translarna.

Portfolio Pulse from Benzinga Newsdesk

May 21, 2024 | 12:46 pm

AENT

CNVS

Alliance Entertainment's Distribution Solutions has extended its partnership with Cineverse Corp, continuing to release a variety of home entertainment titles, including Hallmark movies and cult horror classics.

Portfolio Pulse from Benzinga Newsdesk

May 21, 2024 | 12:44 pm

AAPL

BIDU

TSLA

Baidu Inc (NASDAQ:BIDU) is strengthening its ties with Apple Inc (NASDAQ:AAPL) and Tesla Inc (NASDAQ:TSLA) to expand its AI and autonomous driving technologies. Apple is in preliminary discussions to incorporate Baidu's AI technology, while Baidu is collaborating with Tesla on autonomous driving and lane-level navigation data for Tesla's Full Self-Driving (FSD) system in China.

Portfolio Pulse from Anusuya Lahiri

May 21, 2024 | 12:43 pm

ELWS

Earlywork and Relic have announced a partnership to promote new business development using Web3 technology. This collaboration aims to leverage the innovative capabilities of Web3 to foster growth and development in the business sector.

Portfolio Pulse from Benzinga Newsdesk

May 21, 2024 | 12:43 pm